Report Detail
Global Selicrelumab Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4707759 |
- 09 June, 2026 |
- Global |
- 77 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Selicrelumab market size was valued at US$ 28.09 million in 2025 and is forecast to a readjusted size of US$ 122 million by 2032 with a CAGR of 8.9% during review period.
In 2025, global Sailiximab production reached approximately 100,000 units.Sailiximab is a novel fully humanized anti‑interleukin‑17A monoclonal antibody. It specifically binds to and neutralizes the pro‑inflammatory factor IL‑17A in the human body, inhibits abnormally activated inflammatory responses, and blocks the pathological progression of autoimmune diseases. Featuring a precise targeted mechanism and remarkable anti‑inflammatory efficacy, this drug is mainly clinically applied to autoimmune inflammatory diseases such as psoriasis and ankylosing spondylitis. It demonstrates favorable safety and tolerability, offering a new targeted treatment option for patients with autoimmune disorders and further enriching the layout of innovative drugs in the domestic rheumatology and immunology field.
Selicrelumab represents a promising investigational CD40 agonist monoclonal antibody targeting immune activation for solid tumor immunotherapy. As a key player in the emerging class of immunostimulatory antibodies, it is being evaluated across multiple advanced malignancies, both as monotherapy and in combination with chemotherapy, checkpoint inhibitors, and other immunotherapeutic agents. Its mechanism of action—driving antigen-presenting cell activation and enhancing T‑cell‑mediated antitumor immunity—positions it as a potential cornerstone of next‑generation cancer treatment paradigms. While clinical development continues, the drug faces competitive dynamics from other CD40‑targeted therapies and established immunotherapies, alongside evolving regulatory and reimbursement landscapes that will shape its future market positioning.
This report is a detailed and comprehensive analysis for global Selicrelumab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Selicrelumab market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selicrelumab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selicrelumab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Selicrelumab market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Selicrelumab
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Selicrelumab market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genrix Bio, Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Selicrelumab market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100 mg/1 mL
200 mg/1 mL
Market segment by Dosage Form
Injection
Pre‑Filled Syringe
Market segment by Route Of Administration
Subcutaneous Injection
Intravenous Infusion
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis
Others
Major players covered
Genrix Bio
Novartis AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Selicrelumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Selicrelumab, with price, sales quantity, revenue, and global market share of Selicrelumab from 2021 to 2026.
Chapter 3, the Selicrelumab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Selicrelumab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Selicrelumab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Selicrelumab.
Chapter 14 and 15, to describe Selicrelumab sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Selicrelumab Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100 mg/1 mL
- 1.3.3 200 mg/1 mL
- 1.4 Market Analysis by Dosage Form
- 1.4.1 Overview: Global Selicrelumab Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
- 1.4.2 Injection
- 1.4.3 Pre‑Filled Syringe
- 1.5 Market Analysis by Route Of Administration
- 1.5.1 Overview: Global Selicrelumab Consumption Value by Route Of Administration: 2021 Versus 2025 Versus 2032
- 1.5.2 Subcutaneous Injection
- 1.5.3 Intravenous Infusion
- 1.6 Market Analysis by Sales Channel
- 1.6.1 Overview: Global Selicrelumab Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Retail
- 1.6.4 Online
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global Selicrelumab Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Psoriasis
- 1.7.3 Ankylosing Spondylitis
- 1.7.4 Rheumatoid Arthritis
- 1.7.5 Others
- 1.8 Global Selicrelumab Market Size & Forecast
- 1.8.1 Global Selicrelumab Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global Selicrelumab Sales Quantity (2021-2032)
- 1.8.3 Global Selicrelumab Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Genrix Bio
- 2.1.1 Genrix Bio Details
- 2.1.2 Genrix Bio Major Business
- 2.1.3 Genrix Bio Selicrelumab Product and Services
- 2.1.4 Genrix Bio Selicrelumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Genrix Bio Recent Developments/Updates
- 2.2 Novartis AG
- 2.2.1 Novartis AG Details
- 2.2.2 Novartis AG Major Business
- 2.2.3 Novartis AG Selicrelumab Product and Services
- 2.2.4 Novartis AG Selicrelumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Novartis AG Recent Developments/Updates
3 Competitive Environment: Selicrelumab by Manufacturer
- 3.1 Global Selicrelumab Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Selicrelumab Revenue by Manufacturer (2021-2026)
- 3.3 Global Selicrelumab Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Selicrelumab by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Selicrelumab Manufacturer Market Share in 2025
- 3.4.3 Top 6 Selicrelumab Manufacturer Market Share in 2025
- 3.5 Selicrelumab Market: Overall Company Footprint Analysis
- 3.5.1 Selicrelumab Market: Region Footprint
- 3.5.2 Selicrelumab Market: Company Product Type Footprint
- 3.5.3 Selicrelumab Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Selicrelumab Market Size by Region
- 4.1.1 Global Selicrelumab Sales Quantity by Region (2021-2032)
- 4.1.2 Global Selicrelumab Consumption Value by Region (2021-2032)
- 4.1.3 Global Selicrelumab Average Price by Region (2021-2032)
- 4.2 North America Selicrelumab Consumption Value (2021-2032)
- 4.3 Europe Selicrelumab Consumption Value (2021-2032)
- 4.4 Asia-Pacific Selicrelumab Consumption Value (2021-2032)
- 4.5 South America Selicrelumab Consumption Value (2021-2032)
- 4.6 Middle East & Africa Selicrelumab Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Selicrelumab Sales Quantity by Type (2021-2032)
- 5.2 Global Selicrelumab Consumption Value by Type (2021-2032)
- 5.3 Global Selicrelumab Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Selicrelumab Sales Quantity by Application (2021-2032)
- 6.2 Global Selicrelumab Consumption Value by Application (2021-2032)
- 6.3 Global Selicrelumab Average Price by Application (2021-2032)
7 North America
- 7.1 North America Selicrelumab Sales Quantity by Type (2021-2032)
- 7.2 North America Selicrelumab Sales Quantity by Application (2021-2032)
- 7.3 North America Selicrelumab Market Size by Country
- 7.3.1 North America Selicrelumab Sales Quantity by Country (2021-2032)
- 7.3.2 North America Selicrelumab Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Selicrelumab Sales Quantity by Type (2021-2032)
- 8.2 Europe Selicrelumab Sales Quantity by Application (2021-2032)
- 8.3 Europe Selicrelumab Market Size by Country
- 8.3.1 Europe Selicrelumab Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Selicrelumab Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Selicrelumab Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Selicrelumab Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Selicrelumab Market Size by Region
- 9.3.1 Asia-Pacific Selicrelumab Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Selicrelumab Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Selicrelumab Sales Quantity by Type (2021-2032)
- 10.2 South America Selicrelumab Sales Quantity by Application (2021-2032)
- 10.3 South America Selicrelumab Market Size by Country
- 10.3.1 South America Selicrelumab Sales Quantity by Country (2021-2032)
- 10.3.2 South America Selicrelumab Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Selicrelumab Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Selicrelumab Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Selicrelumab Market Size by Country
- 11.3.1 Middle East & Africa Selicrelumab Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Selicrelumab Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Selicrelumab Market Drivers
- 12.2 Selicrelumab Market Restraints
- 12.3 Selicrelumab Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Selicrelumab and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Selicrelumab
- 13.3 Selicrelumab Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Selicrelumab Typical Distributors
- 14.3 Selicrelumab Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Selicrelumab. Industry analysis & Market Report on Selicrelumab is a syndicated market report, published as Global Selicrelumab Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Selicrelumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
